Hillhouse-backed cancer drug maker InnoCare moves closer to $620m STAR Market listing

Hillhouse-backed cancer drug maker InnoCare moves closer to $620m STAR Market listing

Source: Michael Longmire/Unsplash

14 September, 2021

biopharmaceutical cancer Hillhouse Capital Group innocare pharma STAR Market

Printed by Unregistered user on Sun, 13 Jul 2025 07:24:02 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

PE-VC background remains critical for pre-revenue biotech IPOs, says HKEX executive

SFERS approves $25m investment in Hillhouse Capital’s healthcare fund

Read more from Greater China

Editor’s Take: The Week That Was—July 7-12

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies